01—Abstract
Summary
Summary of the 8-K filed December 26, 2012. Cited figures are marked; the original filing is the authoritative source.
CBRE Group, Inc. (CBRE) has announced a significant development through a Form 8-K filing on December 26, 2012, detailing a Nomination and Standstill Agreement with the ValueAct Group.
This agreement involves the appointment of Brandon B. Boze, a representative from ValueAct Capital, to CBRE's Board of Directors. The ValueAct Group, which collectively owns approximately 9.72%a of CBRE's outstanding common stock as of the agreement date, will have its nominee serve until the 2013 annual meeting and will be nominated for election at that meeting.
This move signals a cooperative approach between CBRE's management and a significant shareholder. The agreement also outlines specific terms and restrictions for both parties. CBRE has agreed to nominate Mr. Boze and work with ValueAct to find a replacement if he steps down, provided ValueAct maintains a minimum ownership stake.
The ValueAct Group, in turn, has agreed to a standstill provision, limiting its ability to engage in certain actions such as proxy solicitations, hostile takeovers, or significant stock accumulations beyond specific thresholds. This agreement aims to ensure a period of stability and collaboration between the company and its substantial shareholder.
02—Key points
Key Highlights
- CBRE Group, Inc. appointed Brandon B. Boze to its Board of Directors.
- Mr. Boze is a representative of ValueAct Capital, which collectively owns approximately 9.72% of CBRE's common stock.
- The appointment is part of a Nomination and Standstill Agreement between CBRE and the ValueAct Group.
- ValueAct Group has agreed to a standstill provision, restricting certain shareholder actions and proxy solicitations.
- CBRE has agreed to nominate Mr. Boze for election at the 2013 annual meeting and to consider a mutually acceptable replacement nominee.
- The agreement includes provisions for board composition and voting support from the ValueAct Group.
- The size of the CBRE Board was increased from 11 to 12 directors to accommodate the new appointment.
03—Questions
Frequently Asked Questions
What is the primary purpose of the Nomination and Standstill Agreement between CBRE and the ValueAct Group?
The agreement's primary purpose is to establish a cooperative framework. CBRE agreed to appoint a representative from ValueAct Capital to its Board, and ValueAct agreed to a standstill, limiting certain aggressive shareholder actions. This aims to create a stable relationship between the company and a significant shareholder.
What is ValueAct Capital's stake in CBRE Group, Inc.?
As of December 21, 2012, the ValueAct Group collectively owned approximately 9.72% of CBRE's outstanding common stock, which equates to 32.0 million shares.
What are the key restrictions placed on the ValueAct Group under the Standstill Agreement?
The ValueAct Group is restricted from actions such as soliciting proxies, engaging in hostile takeovers or mergers, accumulating more than 13.75% of CBRE's stock, or taking actions to control or influence the management or policies of the company, except in Mr. Boze's capacity as a director.
What happens if the ValueAct Group's ownership falls below a certain threshold?
The agreement stipulates that if the ValueAct Group ceases to beneficially own at least 7.5% of CBRE's common stock, Mr. Boze (or his replacement) must offer to resign from the Board, and the Company's obligations under the agreement will cease.
04—Continue